This HTML5 document contains 101 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q65381186
rdf:type
wikibase:Item
schema:description
ensayu clínicu klinisch onderzoek clinical trial клінічне випробування
rdfs:label
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
skos:prefLabel
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
schema:name
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
p:P1476
wds:Q65381186-EB9DD9E7-3774-48AA-B97F-B04665B43C61
wdt:P1476
Phase III Trial of Irinotecan-Based Chemotherapy Plus Cetuximab (NSC-714692) or Bevacizumab (NSC-704865) as Second-Line Therapy for Patients With Metastatic Colorectal Cancer Who Have Progressed on Bevacizumab With Either FOLFOX, OPTIMOX or XELOX
p:P582
wds:Q65381186-03930EF0-733E-4D79-A338-F233F93D708C
wdt:P582
2012-11-01T00:00:00Z
p:P31
wds:Q65381186-892EBCFA-0C17-4CBB-BBB4-32E887D46FA5
wdt:P31
wd:Q30612
p:P580
wds:Q65381186-FA7B219B-841F-47CB-A6D0-1C096D100B17
wdt:P580
2007-06-01T00:00:00Z
p:P17
wds:Q65381186-4C9CE64D-3E74-4CAA-8F56-C32DF9BAE67D
wdt:P17
wd:Q30
p:P6153
wds:Q65381186-6413EDD3-2D1D-40FB-95E0-664D21199CE1 wds:Q65381186-64E179A4-4C44-4714-8936-0F484EC1266D wds:Q65381186-675FE0D4-1A7D-43C3-883E-161F89835688 wds:Q65381186-6AD99C91-8C11-4B6E-B47B-FEC429F2B14C wds:Q65381186-6B95F58D-7766-44E4-8913-79E54493B982 wds:Q65381186-74A70B74-D9A3-419D-B012-8D2FC0A4D378 wds:Q65381186-768BBDE5-CC95-4956-8EF6-D948A03001F5 wds:Q65381186-813CB41A-7004-4FF3-9C6F-62B7AEA1E17F wds:Q65381186-9B060C0B-FCAF-4F8A-A075-2B491B2C4B76 wds:Q65381186-A4CC6D3D-9622-4D79-A359-240E701DFE46 wds:Q65381186-AC3F791B-87B7-4310-8CDF-28F1248FD4ED wds:Q65381186-AE302CBD-BC36-41F2-8A0C-EF83C1751006 wds:Q65381186-AFBC2988-DB3C-4A2D-98B3-5ED3F37ACA2C wds:Q65381186-B260DB93-D720-4CDC-A17E-0728BBAB2EC2 wds:Q65381186-B2B0B505-72C3-4E54-888D-AD8699965326 wds:Q65381186-B92C0500-1BA5-4665-966D-BA46BB6608EF wds:Q65381186-B97A7B16-FAAC-4CF8-914C-FEDAFA6A570A wds:Q65381186-BB5D8157-8622-43A9-A6D6-D1AF9EAE593C wds:Q65381186-CFA708C6-A221-4C16-A57A-5B8C0A9044A9 wds:Q65381186-D38EFD0C-B73B-4C94-908D-B6B3584341CA wds:Q65381186-DFDADA07-A9F4-48C0-B832-320E0194BB94 wds:Q65381186-E0885C25-A6F5-4364-BD46-1475AA6F51BD wds:Q65381186-E1D8676F-D62D-4799-B391-8BFAAB18980A wds:Q65381186-04C3743A-FFDA-452A-89E0-A536B70106D2 wds:Q65381186-0C2E238E-4660-4EBB-BD7C-3E6E8E2476EF wds:Q65381186-0F1A5394-E6DC-442D-8F1D-730A8922C5AF wds:Q65381186-461405A8-7EAE-4601-929C-E3C49E455DB1 wds:Q65381186-483A93EC-1F42-4C9A-84EB-9F6984D2D2B9 wds:Q65381186-5624435B-9F44-418C-89AB-A65741032BCB wds:Q65381186-63B4F8E5-53F1-4A7D-8459-5977FA17B976
wdt:P6153
wd:Q5714832 wd:Q333886 wd:Q6905066 wd:Q49110 wd:Q7191520 wd:Q738258 wd:Q22033932 wd:Q129421 wd:Q2302319 wd:Q1130172 wd:Q6815474 wd:Q14716149 wd:Q30281040 wd:Q4731305 wd:Q30280192 wd:Q30254305 wd:Q5330270 wd:Q3145247 wd:Q87932226 wd:Q30280592 wd:Q7654755 wd:Q30279875 wd:Q219563 wd:Q5592136 wd:Q30281132 wd:Q4614 wd:Q30270451 wd:Q50036507 wd:Q33526980 wd:Q734774
p:P4844
wds:Q65381186-347DF6BD-92CD-4CD0-B3BE-D5E513D30500 wds:Q65381186-C452FEDE-DF31-463D-8319-55A125722DF1 wds:Q65381186-FB7511EA-2DFB-4D37-90F0-EBD0E37D228D wds:Q65381186-E43EB479-79F9-4AA9-92C7-5DC81F267F1A
wdt:P4844
wd:Q50429626 wd:Q238512 wd:Q412197 wd:Q413299
p:P2899
wds:Q65381186-2C8473CE-966F-4742-A444-AF19C60D6209
wdt:P2899
18
p:P1132
wds:Q65381186-13EF0D77-750D-4497-A6A4-FED2639592BE
wdt:P1132
72
p:P767
wds:Q65381186-429A8CDE-6328-4B6F-BD38-4D770A508BA8
wdt:P767
wd:Q7054727
p:P8363
wds:Q65381186-3099F07B-EAD9-43D3-A831-1252A8A30100
wdt:P8363
wd:Q78089383
p:P3098
wds:Q65381186-AA976E41-1476-4B68-B8A8-B39E208DD771
wdt:P3098
NCT00499369
p:P6099
wds:Q65381186-FFA81A6F-0DE0-43AC-AF01-FB47F229AF14
wdt:P6099
wd:Q42824827